Enhance Your Success in the Business of Biotech with BioWorld Today

This is a paid advertisement for SmartBrief readers.

The content does not necessarily reflect the view of SmartBrief or its Association partners.

If you are having trouble viewing this message in your e-mail client, please see the web version here

Try BioWorld Today FREE for 21-Days! PLUS you'll also receive: BioWorld Midday Report, BioWorld Insight and BioWorld International! BioWorld Today ranks as biopharma's most trusted news source for more than 20 years, priding itself on delivering top industry intelligence directly to your inbox every business morning. You'll receive the latest details on a wide range of issues dramatically affecting the industry, helping you to make smart, informed decisions on a daily basis. Coverage Includes: Therapeutic product development from early to late stage Strategic alliances, mergers and acquisitions Corporate financings both public and private Biotech company advancements and setbacks, scientific milestones Global regulatory updates Profiles of new and mature biotech and specialty pharmaceutical firms Big pharma's growing involvement in biotech Plus much more! As a bonus for starting your 21-day trial you will also receive: BioWorld Today Midday Report, daily breaking news, sent to you every afternoon. BioWorld Insight, an in-depth weekly providing incisive updates, analysis and commentary on market data and business trends in the biopharmaceutical industry. BioWorld International, a weekly service that brings you news on international strategic deals, worldwide investment opportunities, country-by-country regulatory issues, product development and insight on emerging biotech companies in Europe and around the world. Enhance your success with these invaluable industry resources! Start your FREE trial today! GET CONNECTED

About this email: BIO SmartBrief will occasionally send emails from our advertising partners promoting products and services determined to be of interest and relevance to our readers. Each email is carefully considered on a case-by-case basis. If you do not want to receive these emails, you can unsubscribe from them by clicking here. SmartBrief, Inc.® 555 11th ST NW, Suite 600, Washington, DC 20004